Hypermethylated B4GALT1 was detected in the mCRC case group and had adverse prognostic effects on CRC.201 Glyco-genes B4GALT1 may act as an additional novel biomarker for CRLM. The gene discussed is B4GALT1; the disease is colorectal carcinoma.